13th Annual Symposium on Global Cancer Research (Overview)

Overview

Save the date: Monday, May 5 - Thursday, May 8, 2025

13th Annual Symposium on Global Cancer Research

Theme: New Models for Participatory Research in Global Oncology: Elevating the Voices of Patients and Providers

By elevating the voice of patients and providers in low- and middle-income countries (LMICs), cancer research can become more responsive, locally relevant, culturally sensitive, empowering, and effective. This also contributes to addressing historical challenges in global oncology, as research models have often focused on clinical data without incorporating the leadership, perspectives, and experiences of those directly impacted by cancer, such as patients, caregivers and providers. At ASGCR 2025, we will showcase collaborative models, where those living with cancer and delivering care for those affected by cancer are active partners and contribute valuable expertise based on their lived experience.

Patients and providers living in LMICs face challenges that significantly impact cancer care and research, including limited access to cancer services. Barriers such as financial constraints, stigma and cultural beliefs, are further compounded by a scarcity of trained healthcare professionals and adequate infrastructure. Our theme highlights equity and inclusivity as key attributes in global cancer research, the importance of actively involving patients and local healthcare providers in all aspects of the research continuum and understanding their challenges and needs throughout the process.

Registration is free of charge and will open in January 2025.

Call for Proposals & Call for Rachel Pearline Award Nominations is now open! See the Proposals and Pearline tabs for details.

The objectives of ASGCR are to:

1. Create opportunities for researchers and program implementers from low resource settings to share their work. 
2. Provide a venue for the global oncology research community to exchange information and identify potential areas for collaboration. 
3. Share science-based initiatives that are reducing the burden of cancer in low resource settings. 

Follow this link to the Archive of ASGCR 2024.

Steering Committee

Frédéric Biemar, PhD, Director, International Affairs, American Association for Cancer Research, Philadelphia, PA, USA​

María Teresa Bourlon, MD, MSc, Representative, Academic Global Oncology Task Force, American Society of Clinical Oncology; Assistant Professor, Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico​

Eduardo Cazap, MD, PhD, FASCO, Founder and First President, Sociedad Latino Americana y del Caribe De Oncología Médica; Editor-in-Chief, ecancer; Co-chair, RINC-SLACOM, Buenos Aires, Argentina​

Laura Esfeller, MA, Patient Advisory Board member, KCCure; Patient Advocate, SWOG Cancer Research Group, San Bernardino, CA, USA

Edith Grynszpancholc, President, Fundación Natalí Dafne Flexer, Buenos Aires, Argentina​

Benda Kithaka, Founder and Executive Director, KILELE Health, Nairobi, Kenya

Racquel Kelly Kohler, PhD, MSPH, Chair, Global Cancer Research Special Interest Group, American Society of Preventive Oncology; Assistant Professor, Department of Health, Behavior, Society and Policy, Rutgers School of Public Health, New Brunswick, NJ, USA​

Keith Martin, MD, PC, Executive Director, Consortium of Universities for Global Health, Washington, DC, USA​

C S Pramesh, MS, FRCS, Convener, National Cancer Grid of India; Director, Tata Memorial Hospital; Professor, Thoracic Surgery (Surgical Oncology), Tata Memorial Centre, Mumbai, India​

Belmira Rodrigues, Managing Director, African Organisation for Research and Training in Cancer, Cape Town, South Africa

Rakiya Saidu, PhD, MPH, Chair, Research Committee, African Organisation for Research and Training in Cancer; Senior Clinical Research Officer, University of Cape Town, South Africa​

Viji Venkatesh, BA, Region Head (India & South Asia), The Max Foundation; Managing Trustee - Friends of Max; Trustee, Being Human The Salman Khan Foundation, Mumbai, India

 

National Cancer Institute, US
Amina Chtourou, MPH, Health Scientist Administrator, Center for Global Health, US National Cancer Institute, Rockville, MD, USA

Mishka Kohli Cira, MPH, Public Health Advisor, Center for Global Health, US National Cancer Institute, Rockville, MD, USA

Kalina Duncan, DrPH, MPH, Branch Director, Partnerships and Dissemination, Center for Global Health, US National Cancer Institute, Rockville, MD, USA

Linsey Eldridge, MPH, Public Health Analyst, Center for Global Health, US National Cancer Institute, Rockville, MD, USA

Nina Ghanem, M.Ed, Communications Director, Center for Global Health, US National Cancer Institute, Rockville, MD, USA

Ophira Ginsburg, MD, MSc, Senior Scientific Advisor for Clinical Research, Center for Global Health, US National Cancer Institute, Rockville, MD, USA

Lillian Matthews, BA, Communications Fellow, Center for Global Health, US National Cancer Institute, Rockville, MD, USA

Mark Parascandola, PhD, MPH, Branch Director, Research and Training, Center for Global Health, US National Cancer Institute, Rockville, MD, USA

Paul Pearlman, PhD, Program Director, Center for Global Health, US National Cancer Institute, Rockville, MD, USA

Douglas Puricelli Perin, JD, MPH, Contractor, Leidos Biomedical Research Institute with support to Center for Global Health, US National Cancer Institute, Rockville, MD, USA

Yelena Shnayder, MS, Public Health Analyst, Center for Global Health, US National Cancer Institute, Rockville, MD, USA

Sudha Sivaram, DrPH, MPH, Program Director, Center for Global Health, US National Cancer Institute, Rockville, MD, USA